J-Y. Hung

759 total citations · 1 hit paper
8 papers, 610 citations indexed

About

J-Y. Hung is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Oncology. According to data from OpenAlex, J-Y. Hung has authored 8 papers receiving a total of 610 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Pulmonary and Respiratory Medicine, 3 papers in Molecular Biology and 3 papers in Oncology. Recurrent topics in J-Y. Hung's work include Lung Cancer Treatments and Mutations (4 papers), Lung Cancer Diagnosis and Treatment (3 papers) and HER2/EGFR in Cancer Research (2 papers). J-Y. Hung is often cited by papers focused on Lung Cancer Treatments and Mutations (4 papers), Lung Cancer Diagnosis and Treatment (3 papers) and HER2/EGFR in Cancer Research (2 papers). J-Y. Hung collaborates with scholars based in Taiwan, Japan and United States. J-Y. Hung's co-authors include Ming‐Jen Tsai, Chao‐Kai Chou, Mien‐Chie Hung, Chun-Yu Lin, Byoung Chul Cho, S-W. Kim, Chul‐Kee Park, Tatsuro Okamoto, Angela Märten and Céline Mascaux and has published in prestigious journals such as Oncogene, Annals of Oncology and Journal of Thoracic Oncology.

In The Last Decade

J-Y. Hung

8 papers receiving 606 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Hypoxic lung cancer-secreted exosomal miR-23a increased angiogenesis and vascular permeability by targeting prolyl hydroxylase and tight junction protein ZO-1

2017 487 citations J-Y. Hung et al. Oncogene profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
J-Y. Hung Taiwan	5	506	392	71	70	53	8	610
Sabine Bender Switzerland	7	227 0.4×	167 0.4×	36 0.5×	42 0.6×	156 2.9×	10	401
Kaitlin Costello United States	6	413 0.8×	254 0.6×	46 0.6×	113 1.6×	48 0.9×	7	530
Yarely M. Salinas-Vera Mexico	13	315 0.6×	267 0.7×	34 0.5×	27 0.4×	104 2.0×	24	451
Lauren McGee United States	6	496 1.0×	256 0.7×	65 0.9×	26 0.4×	112 2.1×	7	563
Elvira D’Ippolito Germany	13	525 1.0×	439 1.1×	58 0.8×	15 0.2×	202 3.8×	26	728
Shin La Shu United States	7	431 0.9×	266 0.7×	63 0.9×	14 0.2×	111 2.1×	9	550
Aarti Sethuraman United States	8	293 0.6×	240 0.6×	12 0.2×	24 0.3×	97 1.8×	15	443
Nadiah Abu Malaysia	15	554 1.1×	406 1.0×	37 0.5×	17 0.2×	143 2.7×	35	708
Benjamin Hirschi Germany	6	278 0.5×	71 0.2×	65 0.9×	59 0.8×	223 4.2×	6	450
Chris Jay United States	12	548 1.1×	391 1.0×	14 0.2×	30 0.4×	55 1.0×	19	711

Countries citing papers authored by J-Y. Hung

Since Specialization

Citations

This map shows the geographic impact of J-Y. Hung's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J-Y. Hung with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J-Y. Hung more than expected).

Fields of papers citing papers by J-Y. Hung

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J-Y. Hung. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J-Y. Hung. The network helps show where J-Y. Hung may publish in the future.

Co-authorship network of co-authors of J-Y. Hung

This figure shows the co-authorship network connecting the top 25 collaborators of J-Y. Hung. A scholar is included among the top collaborators of J-Y. Hung based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J-Y. Hung. J-Y. Hung is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Girard, N., K. Park, Kun Tang, et al.. (2023). LBA5 Amivantamab plus chemotherapy vs chemotherapy as first-line treatment in EGFR Exon 20 insertion-mutated advanced non-small cell lung cancer (NSCLC): Primary results from PAPILLON, a randomized phase III global study. Annals of Oncology. 34. S1304–S1304. 5 indexed citations

2.

Rotow, Julia, Saiama N. Waqar, K. Papadopoulos, et al.. (2023). 1318MO First-in-human study of ABBV-637, an EGFR-targeting BCL-XL–inhibiting antibody-drug conjugate combined with osimertinib (OSI) in relapsed/refractory, EGFR-mutated non-small cell lung cancer (NSCLC). Annals of Oncology. 34. S759–S759. 4 indexed citations

3.

Zhou, Caicun, Kun Tang, S-W. Kim, et al.. (2023). 513MO Amivantamab plus chemotherapy vs chemotherapy as a first-line treatment among Asian patients with EGFR exon 20 insertion-mutated advanced non-small cell lung cancer (NSCLC): PAPILLON subgroup analysis. Annals of Oncology. 34. S1668–S1669. 1 indexed citations

4.

Miura, Satoru, J-Y. Hung, Hyun Ae Jung, et al.. (2021). 145P UpSwinG: Real-world, non-interventional cohort study on TKI activity in patients (pts) with EGFR mutation-positive (EGFRm+) NSCLC with uncommon mutations. Journal of Thoracic Oncology. 16(4). S776–S777. 1 indexed citations

5.

Lin, Chun-Yu, et al.. (2020). Active surveillance for suspected COVID-19 cases in inpatients with information technology. Journal of Hospital Infection. 105(2). 197–199. 14 indexed citations

6.

Hung, J-Y., et al.. (2017). Hypoxic lung cancer-secreted exosomal miR-23a increased angiogenesis and vascular permeability by targeting prolyl hydroxylase and tight junction protein ZO-1. Oncogene. 36(34). 4929–4942. 487 indexed citations breakdown →

7.

Hung, J-Y., et al.. (2014). Angiomotin decreases lung cancer progression by sequestering oncogenic YAP/TAZ and decreasing Cyr61 expression. Oncogene. 34(31). 4056–4068. 74 indexed citations

8.

Chou, Chao‐Kai, et al.. (2006). An attenuated Salmonella oral DNA vaccine prevents the growth of hepatocellular carcinoma and colon cancer that express α-fetoprotein. Cancer Gene Therapy. 13(8). 746–752. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact